Customer Video

Biopharmaceutical Firm AstraZeneca Standardizes on DocuSign for DTM

Biopharmaceutical Firm AstraZeneca Standardizes on DocuSign for DTM

The DocuSign Global Trust Network empowers biopharmaceutical companies like AstraZeneca to simplify clinical operations, decrease development costs, and reduce risk in security and compliance to bring treatments to market sooner and more efficiently. 14 of the top 15 global pharmaceutical companies and 9 of the top 10 Contract Research Organizations (CROs) have standardized on DocuSign for Digital Transaction Management (DTM).